In this podcast Professor Susan O’Brien from Irvine, USA, explains the importance she places on long-term safety and efficacy data when making treatment decisions in R/R CLL. She also describes how she talks through treatment options with patients to determine the management approach best suited to their individual needs.

Professor O’Brien is Associate Director for Clinical Science at the Chao Family Comprehensive Cancer Center in Irvine, USA, Medical Director of the Sue and Ralph Stern Center for Cancer Clinical Trials and Research, and Professor of Medicine at the University of California, Irvine, USA. She has been involved in clinical research that has led to many key discoveries advancing the understanding and treatment of CLL.